Literature DB >> 28913104

Role of inflammation and oxidative stress in the etiology of primary ovarian insufficiency.

Elif Ağaçayak1, Neval Yaman Görük2, Hakan Küsen3, Senem Yaman Tunç1, Serdar Başaranoğlu4, Mehmet Sait İçen1, Ahmet Yıldızbakan1, Hatice Yüksel5, Sevgi Kalkanlı6, Talip Gül1.   

Abstract

OBJECTIVE: The aim of this study was to elucidate the etiology and treatment of primary ovarian insufficiency, which is of unknown cause in 95% of the cases.
MATERIALS AND METHODS: Thirty patients aged 18-40 years who presented to Dicle University Faculty of Medicine Clinic of Obstetrics and Gynecology between June 2012 and January 2014 and were diagnosed as having primary ovarian insufficiency based on their clinical and endocrinologic data, and 30 healthy controls were included in this study.
RESULTS: No significant differences were found between patients with primary ovarian insufficiency and control subjects in demographic data and lipid profile levels, thyroid- stimulating hormone, prolactin, and glucose. However, the neutrophil to lymphocyte ratio and levels of follicle-stimulating hormone, luteinizing hormone, total antioxidant status, total oxidant status, and oxidative stress index were significantly higher in patients with primary ovarian insufficiency than in control subjects. In the correlation analysis, follicle-stimulating hormone exhibited a positive correlation with total oxidant status, oxidative stress index, and the neutrophil to lymphocyte ratio (r=0.573** p<0.001, r=0.584** p<0.001, r=0.541 p<0.001, respectively) and correlated negatively with total antioxidant status (r=-0.437** p<0.001).
CONCLUSION: The neutrophil to lymphocyte ratio, total oxidant status, and oxidative stress index levels are elevated in primary ovarian insufficiency. Therefore, anti-oxidative and anti-inflammatory treatment might be administered to patients in the early stage of primary ovarian insufficiency. However, larger studies are needed to clarify whether these elevated levels are a cause or a consequence of primary ovarian insufficiency.

Entities:  

Keywords:  Premature ovarian insufficiency; inflammation; oxidative stress

Year:  2016        PMID: 28913104      PMCID: PMC5558299          DOI: 10.4274/tjod.00334

Source DB:  PubMed          Journal:  Turk J Obstet Gynecol        ISSN: 2149-9330


  32 in total

Review 1.  Oxidants, oxidative stress and the biology of ageing.

Authors:  T Finkel; N J Holbrook
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

2.  Cigarette smoking damages women's reproductive life.

Authors:  Filiberto Di Prospero; Stefania Luzi; Zeno Iacopini
Journal:  Reprod Biomed Online       Date:  2004-02       Impact factor: 3.828

3.  Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors.

Authors:  P A van Noord; J S Dubas; M Dorland; H Boersma; E te Velde
Journal:  Fertil Steril       Date:  1997-07       Impact factor: 7.329

4.  The use of mitochondrial nutrients to improve the outcome of infertility treatment in older patients.

Authors:  Yaakov Bentov; Navid Esfandiari; Eliezer Burstein; Robert F Casper
Journal:  Fertil Steril       Date:  2009-09-03       Impact factor: 7.329

5.  A new automated colorimetric method for measuring total oxidant status.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2005-10-07       Impact factor: 3.281

6.  Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial.

Authors:  Massimo Tartagni; Ettore Cicinelli; Giovanni De Pergola; Maria Antonietta De Salvia; Cristina Lavopa; Giuseppe Loverro
Journal:  Fertil Steril       Date:  2007-01-29       Impact factor: 7.329

Review 7.  The FMR1 premutation and reproduction.

Authors:  Michael D Wittenberger; Randi J Hagerman; Stephanie L Sherman; Allyn McConkie-Rosell; Corrine K Welt; Robert W Rebar; Emily C Corrigan; Joe Leigh Simpson; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2006-10-30       Impact factor: 7.329

Review 8.  Primary ovarian insufficiency: a more accurate term for premature ovarian failure.

Authors:  Corrine K Welt
Journal:  Clin Endocrinol (Oxf)       Date:  2007-10-29       Impact factor: 3.478

9.  Resveratrol inhibits inflammatory signaling implicated in ionizing radiation-induced premature ovarian failure through antagonistic crosstalk between silencing information regulator 1 (SIRT1) and poly(ADP-ribose) polymerase 1 (PARP-1).

Authors:  Riham Soliman Said; Ebtehal El-Demerdash; Ahmed Shafik Nada; Mohamed M Kamal
Journal:  Biochem Pharmacol       Date:  2016-01-28       Impact factor: 5.858

Review 10.  Premature ovarian failure.

Authors:  Paolo Beck-Peccoz; Luca Persani
Journal:  Orphanet J Rare Dis       Date:  2006-04-06       Impact factor: 4.123

View more
  9 in total

1.  Lipid Profile in Patients With Primary Ovarian Insufficiency: A Systematic Review and Meta-Analysis.

Authors:  Ling Huang; Hanfeng Wang; Minglu Shi; Weizheng Kong; Mei Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

2.  Maternal and Neonatal Complications in Patients With Diminished Ovarian Reserve in In-Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles.

Authors:  Shuang Han; Yiwei Zhai; Qingqing Guo; Yiming Qin; Peihao Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-29       Impact factor: 5.555

3.  Network Pharmacology Approach for Predicting Targets of Zishen Yutai Pills on Premature Ovarian Insufficiency.

Authors:  Yihui Feng; Xinyi Chai; Yingyin Chen; Yan Ning; Ying Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-04       Impact factor: 2.629

4.  Establishment and Mechanism Study of a Primary Ovarian Insufficiency Mouse Model Using Lipopolysaccharide.

Authors:  Si-Ji Lv; Shu-Hui Hou; Lei Gan; Jing Sun
Journal:  Anal Cell Pathol (Amst)       Date:  2021-11-16       Impact factor: 2.916

Review 5.  Complementary and Alternative Medicine for Premature Ovarian Insufficiency: A Review of Utilization and Mechanisms.

Authors:  Yang Fu; Dan-Ni Ding; Ying Shen; Li-Yan Jia; Meng-Yu Yan; Wei Wei; Chang-Hong Song; Feng-Juan Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-01       Impact factor: 2.629

Review 6.  Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis.

Authors:  Wang-Yu Cai; Xi Luo; Wei Wu; Jianyuan Song; Ning-Ning Xie; Cuicui Duan; Xiao-Ke Wu; Jian Xu
Journal:  J Ovarian Res       Date:  2022-09-30       Impact factor: 5.506

7.  Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice.

Authors:  Ying Qin; Akira Iwase; Tomohiko Murase; Chiharu Ishida; Nao Kato; Tomoko Nakamura; Satoko Osuka; Sachiko Takikawa; Maki Goto; Tomomi Kotani; Fumitaka Kikkawa
Journal:  Reprod Biol Endocrinol       Date:  2018-10-27       Impact factor: 5.211

Review 8.  Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease.

Authors:  Aarti Mishra; Roberta D Brinton
Journal:  Front Aging Neurosci       Date:  2018-10-09       Impact factor: 5.750

9.  Advanced Oxidation Protein Products Induce G1/G0-Phase Arrest in Ovarian Granulosa Cells via the ROS-JNK/p38 MAPK-p21 Pathway in Premature Ovarian Insufficiency.

Authors:  Xing-Yu Zhou; Jun Zhang; Ying Li; Ying-Xue Chen; Xiao-Min Wu; Xin Li; Xiao-Fei Zhang; Lin-Zi Ma; Yi-Zhen Yang; Ke-Ming Zheng; Yu-Dong Liu; Zhe Wang; Shi-Ling Chen
Journal:  Oxid Med Cell Longev       Date:  2021-07-27       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.